Lamaze International

39-Week Elective Induction: Where Have We ARRIVEd?

Since its publication, the ARRIVE trial has upended labor management with its finding that compared with expectant management, elective induction at 39 weeks in healthy women and birthing people having first babies reduced cesareans without affecting neonatal outcomes. Is that true? Or is it merely the result of the philosophy and practices of those conducting the trial and managing the pregnancies and labors of its participants? This presentation will make the case that it is the latter.

More Info & Registration